LRP5: a Potential Therapeutic Target in Triple-negative Breast Cancer

被引：0
|
作者：
Maubant, S. [1 ]
Maire, V. [1 ]
Tesson, B. [1 ]
Gentien, D. [1 ]
Marty-Prouvose, B. [1 ]
Cruzalegui, F. [2 ]
Depil, S. [2 ]
Tucker, G. C. [2 ]
Roman-Roman, S. [1 ]
Dubois, T. [1 ]
机构：
[1] Inst Curie, Translat Res Dept, Paris, France
[2] Inst Rech Servier, Oncol Res & Dev Unit, Croissy Sur Seine, France
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)72321-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
524
引用
收藏
页码：161 / 162
页数：2
相关论文
共 50 条
  • [1] LRP5: a potential therapeutic target in triple-negative breast cancer
    Maubant, Sylvie
    Maire, Virginie
    Tesson, Bruno
    Gentien, David
    Marty-Prouvost, Berengere
    Cruzalegui, Francisco
    Depil, Stephane
    Tucker, Gordon C.
    Roman-Roman, Sergio
    Dubois, Thierry
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [2] The depletion of LRP5, unlike that of LRP6, promotes apoptosis in triple-negative breast cancer cells, making it an interesting therapeutic target
    Maubant, Sylvie
    Maire, Virginie
    Tesson, Bruno
    Nemati, Fariba
    Dumont, Aurelie
    Gentien, David
    Marty-Prouvost, Berengere
    Rigaill, Guillem
    De Koning, Leanne
    Vincent-Salomon, Anne
    Barillot, Emmanuel
    Decaudin, Didier
    Pierre, Alain
    Depil, Stephane
    Cruzalegui, Francisco
    Tucker, Gordon C.
    Roman-Roman, Sergio
    Dubois, Thierry
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [3] The depletion of LRP5, unlike that of LRP6, promotes apoptosis in triple-negative breast cancer cells, making it an interesting therapeutic target
    Maubant, Sylvie
    Maire, Virginie
    Tesson, Bruno
    Nemati, Fariba
    Gentien, David
    Marty-Prouvost, Berengere
    Depil, Stephane
    Cruzalegui, Francisco
    Tucker, Gordon
    Roman-Roman, Sergio
    Dubois, Thierry
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [4] Potential therapeutic target for triple-negative breast cancer
    Gilbert, Judith A.
    [J]. LANCET ONCOLOGY, 2012, 13 (08): : E330 - E330
  • [5] Triple-negative breast cancer: investigating potential molecular therapeutic target
    Papa, Anselmo
    Caruso, Davide
    Tomao, Silverio
    Rossi, Luigi
    Zaccarelli, Eleonora
    Tomao, Federica
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (01) : 55 - 75
  • [6] CXCL16 as a potential therapeutic target of triple-negative breast cancer
    Cho, Sun Wook
    Jang, Mi Gyeong
    Sun, Hyun Jin
    Lee, Han Sai
    Song, Young Shin
    Kim, Seong Keun
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [7] NOTCH4 Is a Potential Therapeutic Target for Triple-negative Breast Cancer
    Nagamatsu, Iori
    Onishi, Hideya
    Matsushita, Shojiro
    Kubo, Makoto
    Kai, Masaya
    Imaizumi, Akira
    Nakano, Kenji
    Hattori, Masami
    Oda, Yoshinao
    Tanaka, Masao
    Katano, Mitsuo
    [J]. ANTICANCER RESEARCH, 2014, 34 (1A) : 69 - 80
  • [8] The Internally Truncated LRP5 Receptor Presents a Therapeutic Target in Breast Cancer
    Bjoerklund, Peyman
    Svedlund, Jessica
    Olsson, Anna-Karin
    Akerstroem, Goeran
    Westin, Gunnar
    [J]. PLOS ONE, 2009, 4 (01):
  • [9] CCL5 as a potential immunotherapeutic target in triple-negative breast cancer
    Lv, Dandan
    Zhang, Yan
    Kim, Ha-Jeong
    Zhang, Lixing
    Ma, Xiaojing
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2013, 10 (04) : 303 - 310
  • [10] CCL5 as a potential immunotherapeutic target in triple-negative breast cancer
    Dandan Lv
    Yan Zhang
    Ha-Jeong Kim
    Lixing Zhang
    Xiaojing Ma
    [J]. Cellular & Molecular Immunology, 2013, 10 : 303 - 310
12345